newsfilter
← Latest News
Business Wire·

EndeavorRxⓇ, World's First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17

Akili's Clinically Proven Digital Medicine Now Authorized for Children 8-17, Opening Option to More Patients as Ongoing Stimulant Shortage Persists Akili, Inc. (NASDAQ:AKLI), a leading digital medicine company, today